Identification |
Name: | Ethanone,1-[5-ethyl-2-hydroxy-4-[[6-methyl-6-(2H-tetrazol-5-yl)heptyl]oxy]phenyl]- |
Synonyms: | Ethanone,1-[5-ethyl-2-hydroxy-4-[[6-methyl-6-(1H-tetrazol-5-yl)heptyl]oxy]phenyl]-(9CI); CGS 23356; LY 255283 |
CAS: | 117690-79-6 |
Molecular Formula: | C19H28 N4 O3 |
Molecular Weight: | 360.45 |
InChI: | InChI=1/C19H28N4O3/c1-5-14-11-15(13(2)24)16(25)12-17(14)26-10-8-6-7-9-19(3,4)18-20-22-23-21-18/h11-12,25H,5-10H2,1-4H3,(H,20,21,22,23) |
Molecular Structure: |
|
Properties |
Flash Point: | 300.6°C |
Boiling Point: | 573.4°Cat760mmHg |
Density: | 1.157g/cm3 |
Refractive index: | 1.552 |
Biological Activity: | Selective, competitive antagonist of BLT 2 receptors (IC 50 values are ~ 1 and > 10 μ M at human recombinant BLT 2 and BLT 1 receptors respectively). Inhibits LTB 4 -induced contraction of lung parenchyma (pA 2 = 7.2), and reduces LTB 4 -mediated airway obstruction in guinea pigs following i.v. and oral administration. |
Flash Point: | 300.6°C |
Safety Data |
|
|